FilingReader Intelligence
Lukang Pharmaceutical boosts dividend payout, eyes increased production
March 22, 2025 at 05:00 AM UTC•By FilingReader AI
Shandong Lukang Pharmaceutical (SSE: 600789) announced plans to increase its cash dividend to RMB 1.32 per 10 shares (tax included) for 2024, a move that will distribute RMB 118.62 million to shareholders, representing 30.06% of its net profit attributable to shareholders. The proposal, still subject to shareholder approval, highlights the company's commitment to shareholder returns.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
Primary Source Document
Supplementary Source Documents
Lukang Pharmaceutical 2024 Annual Audit ReportMarch 21, 2025 at 11:09 AM UTC
Summary of Lukang Pharmaceutical's 2024 Annual ReportMarch 21, 2025 at 11:09 AM UTC
Lu'an Pharmaceutical's announcement on capital increase for its wholly-owned subsidiaryMarch 21, 2025 at 11:09 AM UTC
Announcement of Lu'an Pharmaceutical's 2024 Annual Profit Distribution PlanMarch 21, 2025 at 11:09 AM UTC
Lukang Pharmaceutical 2024 Internal Control Evaluation ReportMarch 21, 2025 at 11:09 AM UTC
Lukang Pharmaceutical 2024 Internal Control Audit ReportMarch 21, 2025 at 11:09 AM UTC
News Alerts
Get instant email alerts when Shandong Lukang Pharmaceutical publishes news
Free account required • Unsubscribe anytime